Table 1.
Characteristic | 1st quartile Sample N=1,317 | 2nd quartile Sample N=1,318 | 3rd quartile Sample N=1,318 | 4th quartile Sample N= 1,318 |
---|---|---|---|---|
Age, years* | 48.5 (0.7) | 44.9 (0.6) | 42.2 (0.5) | 40.6 (0.6) |
Race* | ||||
Caucasian | 76.8% | 74.1% | 68.7% | 64.4% |
Other Race | 5.9% | 6.5% | 7.7% | 9.9% |
Mexican-American or other Hispanic | 9.3% | 12.4% | 13.2% | 14.2% |
Non-Hispanic Black | 8.0% | 7.0% | 10.4% | 11.5% |
Gender | ||||
Male | 47.5% | 49.8% | 48.1% | 49.2% |
Female | 52.5% | 50.2% | 51.9% | 50.8% |
BMI† | ||||
Normal | 44.7% | 47.9% | 51.2% | 52.1% |
Underweight | 2.4% | 3.2% | 3.2% | 3.1% |
Overweight | 52.9% | 48.9% | 45.5% | 44.8% |
Smoking* | ||||
Never smoker | 52.6% | 51.6% | 52.9% | 53.7% |
Past smoker | 26.7% | 20.6% | 19.9% | 16.3% |
Current smoker | 21.2% | 27.8% | 27.2% | 30.0% |
Alcohol use | ||||
None | 14.7% | 16.0% | 14.5% | 13.3% |
Below limit | 69.2% | 69.4% | 72.9% | 74.6% |
Above limit | 16.0% | 14.6% | 12.6% | 12.1% |
Cancer history* | ||||
No | 88.0% | 90.9% | 93.6% | 93.5% |
Yes | 12.0% | 9.1% | 6.4% | 6.5% |
Caffeine, g/day* a | ||||
1st Quartile | 19.1% | 14.9% | 18.3% | 23.5% |
2nd Quartile | 21.0% | 24.0% | 23.8% | 22.1% |
3rd Quartile | 26.4% | 29.1% | 25.4% | 25.2% |
4th Quartile | 33.5% | 32.0% | 32.5% | 29.3% |
Prescription medication* | ||||
Did not use in past month | 40.4% | 49.6% | 53.5% | 54.5% |
Used in past month | 59.6% | 50.4% | 46.5% | 45.5% |
Menopausal status/postmenopausal hormone use (women only)*b | ||||
Premenopausal | 56.3% | 60.3% | 67.5% | 73.1% |
Postmenopausal/Never used | 22.7% | 18.7% | 17.5% | 14.1% |
Postmenopausal/Past, not current | 12.4% | 13.7% | 8.6% | 8.8% |
Postmenopausal, Past/unknown current | 3.0% | 3.5% | 2.2% | 0.3% |
Postmenopausal/Current | 5.5% | 3.8% | 4.2% | 3.7% |
differences across quartiles significant at 0.001 level
differences across quartiles significant at 0.05 level
1st − <10; 2nd: 10−<91 ; 3rd − 91−<208; and 4th −>208 mg
N of women for each % quartile: 1st quartile: Sample N = 603, Weighted N =11,899,351; 2nd quartile: Sample N = 616, Weighted N = 12,182,219; 3rd quartile: Sample N = 633, Weighted N =12,507,047; 4th quartile: Sample N = 586 Weighted N =11,381,258